OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial

Por Kim, JH, Kamasuta, C, Trichavaroj, R, Kaewkungwal, J, Chantakulkij, S, Ratto-Kim, S, Eamsila, C, Sukwit, S, Nitayaphan, S, Pitsuttihum, P, Michael, NL, Chiu, J, Rerks-Ngarm, S, de Souza, MS, Paris, RM
Publicado em 2009

OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial

Por de Souza, MS, Trichavaroj, R, Schuetz, A, Chuenarom, W, Phuang-ngem, Y, Jongrakthaitae, S, Ratto-Kim, S, Nitayaphan, S, Dally, L, Rerks-Ngam, S, Tartaglia, J, Francis, D, Michael, NL, Paris, RM, Kim, JH
Publicado em 2009